Drug recall · April 1, 2026
Levothyroxine Sodium Tablets USP 150 mcg recall
Why: Subpotent Drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
- Lots / codes
Lot 16240062A, exp date 3/2026
- Quantity
- 1315 bottles
- Company
- Macleods Pharma USA, Inc, Princeton, NJ
- Distribution
- Nationwide
- Initiated
- February 26, 2026 · Voluntary: Firm initiated
- Classified
- March 24, 2026
- Reported
- April 1, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.